Benping Zhang Yaling Li Weijie Xu Bei Peng Gang Yuan
10.3389/fendo.2020.583565
Front Endocrinol (Lausanne)
2020 Oct 26;11:583565.
dysthyroid optic neuropathy grave’s disease grave’s ophthalmopathy orbital decompression rituximab
CC BY
https://pubmed.ncbi.nlm.nih.gov/33193097/
Decompression, Surgical / adverse effects Graves Ophthalmopathy / surgery Inflammation / prevention & control Ophthalmologic Surgical Procedures / adverse effects Optic Nerve Diseases / drug therapy Rituximab / therapeutic use
Decompression, Surgical / adverse effects Graves Ophthalmopathy / surgery Inflammation / prevention & control Ophthalmologic Surgical Procedures / adverse effects Optic Nerve Diseases / drug therapy Rituximab / therapeutic use Case Reports Antineoplastic Agents, Immunological / therapeutic use Graves Ophthalmopathy / pathology Humans Inflammation / etiology Inflammation / pathology Male Middle Aged Optic Nerve Diseases / etiology Optic Nerve Diseases / pathology Prognosis Retrospective Studies Antineoplastic Agents, Immunological Rituximab
PMC7649761
33193097
Use of Rituximab After Orbital Decompression Surgery in Two Grave's Ophthalmopathy Patients Progressing to Optic Neuropathy
2020